Hair loss is a common problem that affects millions of people around the world. For many, it is not just about appearance but also confidence and emotional well-being.
Scientists have been searching for safer and more effective treatments for years, as current options often come with unwanted side effects. Now, a new study suggests that a promising solution may be on the horizon.
Researchers from Kyungpook National University School of Medicine, working with an international team, have developed a new type of treatment that may help promote hair growth without the common risks seen in existing drugs. Their findings were published in the journal Biomedicine & Pharmacotherapy.
At present, there are only two main drugs approved for treating hair loss: minoxidil and finasteride. Minoxidil is usually applied to the scalp, but it can cause irritation in some people.
Finasteride is taken as a pill and works by affecting male hormones, which can lead to side effects such as sexual problems in men. It is also not recommended for women of childbearing age. These limitations make it clear that safer alternatives are needed.
The new research focused on a different approach. Scientists have known that a natural hormone in the body, called erythropoietin, or EPO, can help stimulate hair growth.
EPO works by attaching to specific receptors on hair follicle cells and encouraging them to grow. However, using EPO as a treatment is not practical because it also increases the production of red blood cells, which can lead to serious health risks.
To solve this problem, the research team used advanced computer modeling to design a new molecule. Instead of using the whole EPO protein, they carefully selected only the part that helps with hair growth. They removed the parts that cause unwanted side effects. By doing this, they created a new peptide, which they named MLPH.
This peptide is much smaller than the original protein but still keeps the ability to activate hair growth. The design process allowed the researchers to focus only on the helpful function while avoiding harmful effects.
The team tested MLPH in laboratory experiments using human hair follicle tissues and in animal studies with mice. The results were encouraging. The new peptide increased the levels of a substance called insulin-like growth factor-1, or IGF-1, which plays an important role in hair growth.
In the mouse studies, the peptide was able to move hair follicles from a resting phase, when hair is not growing, into an active growth phase. This change is important because it is the key step in starting new hair growth. The effects were similar to those seen with minoxidil, one of the most commonly used treatments today.
Importantly, the researchers also checked for side effects. Unlike EPO, the new peptide did not increase red blood cell production. This suggests that it may avoid the serious risks that have limited the use of similar treatments in the past.
Hair loss affects about one billion people worldwide, making it a major health and economic issue. The global market for hair loss treatments is expected to grow rapidly in the coming years. Because of this, the development of safer and more effective treatments could have a significant impact both medically and economically.
The researchers believe that their work could lead to a new generation of hair loss treatments that are suitable for both men and women. By focusing on the biological mechanisms behind hair growth, rather than hormones, this approach may avoid many of the problems seen with current drugs.
In reviewing the study, the findings are promising and show the power of combining biology with modern technology such as computational modeling.
The ability to design a molecule that keeps beneficial effects while removing harmful ones is a major step forward. However, it is important to note that these results are still in the early stages. More research, including human clinical trials, will be needed before the treatment can be widely used.
Overall, this study provides hope for a safer and more effective way to treat hair loss in the future. If further studies confirm these results, it could offer a new option for millions of people looking for a solution without worrying about serious side effects.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and berry that can prevent cancer, diabetes, and obesity.
For more health information, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing vitamin D supplements could strongly reduce cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
